UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
CLINICAL RESEARCH

ICON plc

I

ICON plc

Clinical ResearchDublin, Ireland
Visit Website

About ICON plc

ICON plc is one of the world's largest contract research organisations, conducting clinical trials across more than 100 countries and partnering with pharmaceutical, biotechnology, and medical device companies at every stage of drug development. Founded in Dublin in 1990, ICON has grown from a single Irish CRO into a global operation with tens of thousands of employees and a presence spanning North America, Europe, Asia-Pacific, and beyond.

Clinical Development at Scale

ICON's core business centres on clinical trial management, spanning Phase I through Phase IV studies across a broad range of therapeutic areas. The company manages the full spectrum of trial operations, from protocol design and site selection to patient recruitment, data management, biostatistics, and regulatory submissions. Its scale allows it to run complex, multinational studies that require coordination across dozens of countries simultaneously.

The company's 2021 merger with PRA Health Sciences significantly expanded its capabilities and workforce, creating one of the two or three largest CROs in the global market by revenue. That transaction reinforced ICON's position alongside the handful of organisations capable of supporting large-scale late-phase and commercial programmes for the world's biggest pharmaceutical sponsors.

Technology and Decentralised Trials

ICON has invested substantially in technology-enabled trial delivery, including decentralised and hybrid clinical trial models that allow patient participation outside traditional site settings. Its FIRECREST platform supports site and investigator training and management, while its data science capabilities cover real-world evidence, pharmacovigilance, and patient-centred outcomes research.

Listed on the Nasdaq stock exchange under the ticker ICLR and also quoted on Euronext Dublin, ICON operates as a publicly traded company with a headquarters in Dublin, Ireland. Its client base includes the majority of the world's top-twenty pharmaceutical companies, as well as emerging biotech sponsors and government health agencies.

Further information is available at iconplc.com.

Similar Companies

More in Clinical Research

A

Affinity

Combining mobile nursing, teletrials and a dedicated oncology unit, Affinity Clinical Research Services brings clinical research capability directly to patients across Perth and the wider Australian continent. Operating from Doubleview in Western Australia and from a research facility within Hollywood Private Hospital Medical Centre, the organisation serves pharmaceutical sponsors, biotechnology companies and independent investigators seeking a flexible, patient-centred site partner. Affinity's service model covers the full research lifecycle, from protocol development and site feasibility through participant recruitment, data collection and publication support. The company's direct-to-patient and mobile trial services reduce the burden on participants who would otherwise be unable to access a fixed trial site, extending sponsor reach into regional and rural populations. This approach aligns with ICH-GCP guidelines and is adapted to the specific needs of each patient group and study design. The dedicated oncology division, Affinity Oncology, was established in 2016 and draws on clinical staff with more than a decade of experience in cancer trials. On-site resources include PET/CT imaging, a compounding pharmacy and a chemotherapy infusion suite, allowing complex oncology studies to run without reliance on third-party facilities. Beyond oncology, Affinity supports studies across a broad range of therapeutic areas and can assist private investigators running sponsor-initiated or investigator-initiated research. Further information is available at affinityresearch.com.au.

View profile
W

Worldwide Clinical Trials

Operating across more than 60 countries, Worldwide Clinical Trials is a full-service contract research organisation built around a single discipline: clinical development. Founded in 1986, the company has spent nearly four decades focusing exclusively on Phase I through Phase IV studies, giving it a depth of therapeutic and regulatory expertise that generalist CROs rarely match. The organisation is particularly well regarded for its work in central nervous system research, where it operates dedicated CNS units with specialist investigators and patient populations. Alongside CNS, Worldwide Clinical Trials carries strong capabilities in cardiovascular, metabolic, and rare disease development, areas where patient recruitment complexity and protocol design demand experienced hands. Its Phase I infrastructure includes purpose-built clinical pharmacology units that support first-in-human studies, bioavailability and bioequivalence work, and early proof-of-concept programmes. This early-phase foundation connects seamlessly into its late-phase trial management, allowing sponsors to maintain a single CRO relationship from initial dosing through to regulatory submission. Worldwide Clinical Trials works primarily with mid-size and emerging biopharmaceutical companies, positioning itself as a committed partner rather than a high-volume processor. That focus has earned it a reputation for therapeutic expertise and operational flexibility, qualities that sponsors managing complex or novel compounds tend to prioritise. Headquarters are in Wayne, Pennsylvania, with a global network of offices and clinical sites spanning North America, Europe, and beyond. Further information is available at worldwide.com.

View profile
C

Charles River Laboratories

Charles River Laboratories is one of the world's most recognised early-stage contract research organisations, providing the foundational scientific services that pharmaceutical and biotechnology companies rely on to move candidates from discovery through to regulatory submission. Founded in 1947 in Boston, Massachusetts, the company began as a supplier of purpose-bred laboratory animals and has since grown into a global CRO spanning drug discovery, safety assessment, and manufacturing support. Early-Stage Research & Preclinical Services The company's core strength lies in preclinical and non-clinical research. Charles River operates one of the largest networks of Good Laboratory Practice-accredited safety assessment facilities globally, conducting toxicology, pathology, and pharmacokinetic studies that satisfy regulatory requirements across the US, Europe, and Asia. Its research models business, which traces directly to its founding purpose, remains a significant operation, supplying inbred and outbred rodent models, immunocompromised strains, and specialised models to research institutions and industry clients worldwide. Discovery Services & Biologics Testing Beyond preclinical safety, Charles River has expanded substantially into integrated drug discovery services, offering medicinal chemistry, in vitro biology, and DMPK capabilities that allow clients to outsource entire lead-optimisation programmes. The company's biologics and pharmaceutical product testing division provides release testing, stability studies, and microbial safety testing for biological drugs and advanced therapies, a segment that has grown considerably as the industry has shifted toward large-molecule and cell and gene therapy pipelines. Headquartered in Wilmington, Massachusetts, and listed on the New York Stock Exchange under the ticker CRL, Charles River employs tens of thousands of scientists and support staff across more than 100 sites in approximately 20 countries. Its scale means it serves virtually every major pharmaceutical company alongside hundreds of smaller biotechnology firms and academic research centres. The company's positioning as a single-source partner for early-stage research, from target validation through to IND-enabling studies and into manufacturing quality testing, gives it a distinctive role in the global drug development supply chain. Further information is available at criver.com.

View profile
AdvertisementTeksyte LTD

List Your Company

Showcase your company to thousands of pharma professionals.

Submit Listing

Advertise With Us

Reach decision-makers in the pharmaceutical industry.

Learn More

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy